Synthetic DMARDs May Blunt Pneumococcal Vaccine Response in Systemic Sclerosis

Pneumococcal vaccination yields a satisfactory antibody response in patients with systemic sclerosis (SSc), but synthetic disease-modifying antirheumatic drugs (DMARDs) might reduce the vaccine response in these individuals, according to a report from Sweden.
Reuters Health Information

http://ift.tt/2n7wPgR